Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong
· Delayed Price · Currency is HKD
44.00
+2.66 (6.43%)
At close: Dec 5, 2025
HKG:2591 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -221.89 | -174.69 | -733.38 |
| Depreciation & Amortization | 11.27 | 16.76 | 19.54 |
| Other Amortization | 0.17 | 0.17 | 0.1 |
| Loss (Gain) From Sale of Assets | - | 0.3 | - |
| Loss (Gain) From Sale of Investments | 0.08 | -0.19 | -1.13 |
| Stock-Based Compensation | 19.99 | 16.04 | 538.9 |
| Other Operating Activities | -9.77 | -12.58 | -8.43 |
| Change in Inventory | -33.8 | -25.59 | 0.23 |
| Change in Accounts Payable | 58.84 | 2.71 | 15.64 |
| Change in Other Net Operating Assets | 14.29 | 14.46 | 3.92 |
| Operating Cash Flow | -169.42 | -162.62 | -164.6 |
| Capital Expenditures | -5.04 | -3.95 | -12.05 |
| Sale (Purchase) of Intangibles | -2.24 | -0.38 | -0.15 |
| Investment in Securities | 218.1 | 280.28 | -145.02 |
| Investing Cash Flow | 210.82 | 275.95 | -157.21 |
| Short-Term Debt Issued | - | 9.9 | 1 |
| Total Debt Issued | 49.93 | 9.9 | 1 |
| Short-Term Debt Repaid | - | -1 | -1 |
| Long-Term Debt Repaid | - | -0.81 | -4.45 |
| Total Debt Repaid | -12.31 | -1.81 | -5.45 |
| Net Debt Issued (Repaid) | 37.61 | 8.1 | -4.45 |
| Issuance of Common Stock | - | 250 | 367.81 |
| Other Financing Activities | -3.62 | -3.26 | -11.66 |
| Financing Cash Flow | 34 | 254.84 | 351.71 |
| Foreign Exchange Rate Adjustments | 0.25 | 0.7 | 0.71 |
| Net Cash Flow | 75.64 | 368.87 | 30.61 |
| Free Cash Flow | -174.46 | -166.57 | -176.64 |
| Free Cash Flow Per Share | -0.41 | -0.40 | -0.46 |
| Cash Interest Paid | 0.43 | 0.87 | 2.32 |
| Levered Free Cash Flow | - | -95.73 | - |
| Unlevered Free Cash Flow | - | -95.18 | - |
| Change in Working Capital | 30.73 | -8.41 | 19.79 |
Source: S&P Capital IQ. Standard template.
Financial Sources.